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Purpose: The use of L-arginine and potassium chloride separately as supplements has been 
reported to result in altered vascular reactivity. The concentration of either agent used has 
varied widely and there has been no report on the outcome of combined supplementation 
with both agents on vascular reactivity. We therefore designed this study to measure thoracic 
aortic ring reactivity after five-week co-supplementation with 1% L-arginine and 0.75% 
potassium chloride.  
Methods: Endothelium-intact and endothelium-denuded aortic rings obtained from Sprague-
Dawley rats which received the combined supplements were subjected to graded 
concentrations of carbachol or noradrenaline in organ baths. The maximum responses (Emax) 
and the negative logarithm of the concentration producing 50% of maximum responses (pD2) 
were computed as indices of vasoreactivity.   
Results: Co-supplementation significantly enhanced the relaxant effects of carbachol 
irrespective of the status of the endothelium although relaxation was by far higher in 
endothelium-intact rings. In concentration-response curves obtained with noradrenaline, Emax 
and pD2 values were significantly (P < 0.05) reduced in endothelium-intact rings obtained 
from rats which received the supplements. In endothelium-denuded rings, responses to 
noradrenaline were not significantly different from those of control.   
Conclusion: Co-supplementation with the agents enhances the relaxant effect of carbachol 
independent of the status of the endothelium while attenuating responses to noradrenaline in 
endothelium-dependent manner. This suggests that oral L-arginine and potassium co-
supplementation may possess beneficial vascular effects. 
  
Keywords: Potassium chloride, L-arginine, co-supplementation, aortic rings 
 
 




*Corresponding author: E-mail: ozolua@uniben.edu or rozolua2000@yahoo.co.uk; Tel: + 234-(0)802-352-8166 
Ozolua & Omogbai  
Trop J Pharm Res, June 2009; 8 (3):  210 
INTRODUCTION 
 
Prevention of hypertensive disease has 
focused, in recent times, on the use of dietary 
supplements, several of which are rich in 
potassium
1
. This has arisen following several 
studies in humans and animals, which show 
that potassium supplementation and 
ingestion of potassium-rich diets reduce 
blood pressure and the tendency to develop 
the disease
1-3
. In our previous study, we 
showed that 0.75% potassium 
supplementation in drinking water reduces 
blood pressure in normotensive animals and 
blunts responses to some vasoactive drugs
4
. 
L-arginine as a precursor of nitric oxide has 
also been widely reported to reduce blood 
pressure in normotensive humans and 
animals although the concentrations used 




Several mechanisms have been proposed for 
the anti-hypertensive effect of potassium. 
These include increased endothelium-
mediated dilatation of blood vessels
8,9
, 






thereby leading to hyperpolarization of blood 
vessels
10,11
, and reduced response to 




While the possible mechanisms of action of 
potassium seem to be poorly understood and 
have generated some controversy, the use of 
L-arginine seems more defined and better 
understood. Supplementation with L-arginine 
(the precursor of the vasodilatory autacoid 
nitric oxide) has been widely reported to 
increase the tendency of blood vessels to 
dilate
13,14
. Inhibition of the synthesis of nitric 
oxide by administration of L-nitroarginine 
methyl ester has been known to result in 




There has been no report on the vascular 
effects of co-supplementation with both 
potassium chloride (KCl) and L-arginine. We 
therefore designed experiments in order to 
study the effects of co-supplementation on 
the reactivity of aortic rings obtained from 
Sprague-Dawley rats and the dependence of 
these effects on the endothelium. 
 




Sprague-Dawley rats weighing between 200 
and 300 g were obtained from the animal 
house of the Department of Physiology, 
Ambrose Alli University, Ekpoma, Edo State, 
Nigeria. The animals were allowed two weeks 
of acclimatization before they were divided 
into two experimental groups (six animals per 
group). One group (the control) was given tap 
water while the second group (treated) 
received 0.75 %w/v KCl + 1 %w/v L-arginine 
in the tap water. Supplementation was done 
for a period of 5 weeks since our previous 
reports on potassium supplementation was 
for that length of time
4,10
. All animals were 
housed in standard cages and had free 
access to pellets (Bendel Feeds and Flour 
Mills Ltd, Ewu, Nigeria) and the particular 
drinking fluid. The animals were exposed to 
natural lighting conditions and were handled 
according to international protocols for use of 
animals in experiments (National Institute of 
Health USA: Public Health Service Policy on 
Humane Care and Use of Laboratory 
Animals, 2002; and the 1986 European 
Convention for the protection of Vertebrate 
Animals Used for Experimental and other 
Scientific Purposes) in the absence of a 
functional local ethical committee on the use 
of animals. At the end of supplementation, 
animals were sacrificed under thiopentone 
sodium (15 mg/kg) anaesthesia. 
 
Measurement of fluid intake  
 
In order to ascertain that the animals actually 
drank the fluid which contained the 
supplements, average daily fluid intake in the 
groups was measured for the 5 weeks of 
supplementation. Animals drank from a 
graduated water bottle and at the same time 
each day, the decrement in the amount of 
fluid consumed over 24 h was measured by 
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subtracting the day’s reading from that of the 
previous day.  
 
Isolated aortic ring experiments  
 
The thoracic aortae were quickly dissected 
out of the sacrificed animals and placed in 
physiological salt solution (PSS). The tissues 
were cleaned of adherent connective tissues 
and cut into rings of 2 mm length. In 
endothelium-denuded rings, denudation was 
achieved by gently rubbing the intimal layer 
of the vessel with a wire. The rings were 
suspended in L-shaped wire loops in 10 ml 
organ baths containing PSS.  The upper loop 
was attached to a Grass Model FT03 force 
transducer connected to a Grass Model 7D 
polygraph (Grass Instruments Co., Quincy, 
MA, USA).  The PSS was made of the 
following composition (mM/L):  NaCl 119, KCl 
4.7, NaHCO3 24.9, KH2PO4 1.2, MgSO4 1.2, 
CaCl2 1.6, glucose 11.5. The PSS was 
bubbled throughout with 95% O2 - 5% CO2 
gas mixture (BOC Gases, Nig. Plc) with the 
pH and temperature maintained at 7.4 and 
37
o
C respectively.  The rings were given a 
resting force of 1 g
10
. An equilibration period 
of 60 min was allowed after which rings were 
stimulated twice at 15 min intervals with 100 
mM K
+
. Aortic tissue viability was closely 
monitored within 6-hour period of 
experiments. This was ascertained by the 
observation that force produced by 100 mM 
K
+
 for each ring was reproducible within this 
period. 
 
Rings from both groups were exposed to 
cumulative concentrations of noradrenaline 
ranging from 1 x 10
-10 
M to 1 x 10
-4 
M.  
Vasorelaxant effects of carbachol were 
studied by precontracting the rings with 
noradrenaline at a concentration producing 
75% of maximal noradrenaline-induced 
contraction obtained from pilot study (1 x 10
-6 
M for control and 1 x 10
-7
 M for the treated). 
Contractile responses from the pilot studies 
were 75.2 ± 4.7% and 74.3 ± 5.5% for 1 x 10
-
6 
M NA (control) and 1 x 10
-7
 M NA (treated) 
respectively. This was followed by the 
addition of the relaxant; after steady 
contraction had been established (time-
dependent control experiments showed that 
the precontraction induced by noradrenaline 
remained stable for the duration of the 




Noradrenaline and carbachol were obtained 
from Sigma (UK) and were prepared fresh 
each day by dissolving in distilled water. L-
arginine and KCl for supplementation were 
obtained from BDH chemicals (UK) and were 
prepared once a week. All other chemicals 
and reagents were of analytical grade and 
were obtained from either of Sigma, May & 




Aside from daily fluid intake in the two groups 
which is presented as means, all other data 
are presented as mean ± SEM (standard 
error of the mean) and n represents the 
number of rats from which aortic rings were 
taken. Emax (the maximum response by aortic 
rings) are presented either as contractile 
force (mg) produced by rings exposed to 
noradrenaline, or as percentage of maximum 
relaxation response to carbachol following 
noradrenaline precontraction. Comparison of 
Emax and pD2 (negative log of the 
concentration producing 50% contractile 
response to noradrenaline) values were 
made by use of Student’s t-test. In all cases, 
P < 0.05 was taken as indicating statistically 





The daily fluid intake by the animals as 
measured for 35 days shows fluctuating but 
insignificantly different patterns of 
consumption between the two groups (Fig. 
1). Mean daily volume of the fluid consumed 
by the control group was 133.0 ± 2.2 ml and 
130.0 ± 2.0 ml for the L-arginine + KCl co-
supplementation group.  
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Figure 1: Daily fluid intake by rats on tap water 
(control♦) and L-arginine + KCl co-supplemented fluid 
(treated •). Means of daily fluid intake for the 5 weeks 
















Figure 2: The relaxant effect of carbachol on aortic rings 
from rats given tap water (control) or L-arginine and KCl 
co-supplemented fluid for 5 weeks. There is significant 
difference in the maximum relaxant effect irrespective of 
the status of the endothelium. (■), treated endothelium-
intact; (○), control endothelium-denuded; (∆), control 
endothelium-intact; (▼), treated endothelium-denuded. n 
= 6 per group.  
 
Co-supplementation with L-arginine and KCl 
significantly enhanced the relaxation of 
endothelium-denuded aortic rings to effective 
concentrations of carbachol (Fig. 2). There 
was increase in the Emax compared to values 
in control (22.3 ± 3.6 versus 12.1 ± 2.7 %). 
Treatment also significantly altered the 
maximum relaxation to carbachol in 
endothelium-intact aortic rings (63.4 ± 2.8 
versus 49.2 ± 4.3%). 
 
Endothelium-intact aortic rings obtained from 
rats which received the supplements showed 
significantly attenuated responses to 
noradrenaline (Fig. 3). Emax values were 
significantly lower in endothelium-intact rings 
from the treated group compared to the 
control: 1315.5 ± 106.2 versus 1690.1 ± 68.1 
mg (P < 0.05). Similarly, the pD2 values were 
significantly lower in the endothelium-intact 
rings from the treated group than the control 
(7.0 ± 0.1 versus 7.4 ± 0.1, P < 0.05). 
Although endothelium-denuded rings from 
the treated group showed lower Emax and 
higher pD2 values than rings obtained from 
the controls, these values were not 
significantly different. The respective values 
are 2069.5 ± 80.1 versus 2356.8 ± 228.0 mg 















Figure 3: Effects of noradrenaline on aortic rings from 
rats given tap water (control) or L-arginine and KCl co-
supplementation (treated) for 5 weeks. Supplementation 
significantly attenuated the responses of endothelium-
intact aortic rings compared to control. The difference 
between maximum contractile responses of endothelium-
denuded rings from both groups is not significant.  (■), 
treated endothelium-intact; (○), control endothelium-
denuded; (∆), control endothelium-intact; (▼), treated 




The combination of 1% L-arginine and 0.75% 
KCl as supplements in drinking fluid of rats 
has been shown in the present study to alter 
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carbachol. In rats which received the 
supplements, responses of endothelium-
intact aortic rings to noradrenaline were 
attenuated while there was enhanced 
relaxation by aortic rings to carbachol 
irrespective of the status of the endothelium.  
 
In our previous study we showed that while 
supplementation with 0.75% KCl for five 
weeks did not affect acetylcholine-induced 
relaxation in endothelium-intact aortic rings, it 
significantly enhanced acetylcholine-induced 
relaxation in endothelium-denuded rings
17
. 
Similarly, responses to vasoconstrictors such 
as noradrenaline and 5-HT were attenuated 
in aortic rings from potassium-supplemented 
rats.
17
 Decreased vasoconstriction to 
noradrenaline and enhanced relaxation to 
acetylcholine have also been reported in 
DOCA-salt hypertensive rats which were 
placed on 0.8% L-arginine supplementation
18
. 
Consequently, the present data suggest that 
the combined supplements further enhanced 
carbachol-induced relaxation in an 
endothelium-independent manner.  
 
This enhanced carbachol-induced relaxation 
is possibly due to the fact that basal nitric 
oxide production was increased by the 
increased provision of the precursor L-
arginine although serum and urinary L-
arginine levels were not measured. Several 
workers have found that supplementation 
with L-arginine enhances relaxant action of 
acetylcholine while improving 
haemodynamics in human and animal 
experiments
7,18,19
. Nitric oxide itself causes 
relaxation through the cyclic GMP pathway 
while also facilitating the opening of 
potassium channels with the resultant 
vascular smooth muscle cell 
hyperpolarisation
20
. Similarly, several reports 
have suggested that potassium 
supplementation enhances endothelium-
dependent relaxations, increased vascular 





ATPase enzymes and reduced vascular 
reactivity to pressor agents
8-12
. Although 
membrane potentials were not measured in 
the present study, it seems that vascular 
smooth muscle cell hyperpolarisation may 
only be a part mechanism since in our 
previous report potassium channel blockade 
with tetraethylammonium only partially 
reversed the enhanced relaxant effect of 
levcromakalim and sodium nitroprusside in 





Although several protocols and 
concentrations have been used each for L-
arginine and KCl, previous workers have 
indicated that the concentrations used in the 
present study are well tolerated by the 
animals. For example the animals become 
adapted to the increased potassium load 
after weeks of supplementation
21
. In the case 
of L-arginine, concentrations far in excess of 
what has been used in the present study 
have been reportedly well tolerated
22
. The 
ability of the animals to tolerate the 
supplements is accentuated by the facts that 
fluid consumption was not significantly 
different in the two groups and that there 




Combining potassium chloride and L-arginine 
as supplements enhances carbachol-induced 
relaxation in an endothelium-independent 
manner while blunting vasoconstriction by 
noradrenaline in endothelium-intact aortic 
rings. These are beneficial vascular effects in 
the non-pharmacologic prophylaxis of 
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